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INTRODUCTION
Inflammatory myofibroblastic tumor (IMT) is a mesenchymal neoplasm of intermediate biological potential which rarely recurs or metastasize. [1] They present as solitary or multiple mass lesions in the abdominopelvic region, lung, mediastinum, and retroperitoneum of children and young adults. [1] Only 8 cases of post hematopoietic stem cell transplantation (HSCT) IMTs and even fewer in post solid organ transplant patients have been reported till date. [2] [3] [4] In 2011, Mariño-Enríquez et al. [2] described a novel variant of IMT -epithelioid inflammatory myofibroblastic sarcoma (EIMS). They are characterized by an epithelioid morphology and prominent neutrophilic inflammatory infiltrate. Clinically, they are more aggressive tumors with a shorter disease-free survival. [3] Approximately 50% of IMTs aberrantly express clonal rearrangements of ALK gene located on chromosome 2p235. [5] Only 20 cases of EIMS have been reported thus far but none in a posttransplant setting. [6] To the our knowledge, this is the first case of IMT possibly of epithelioid sarcomatous type in a liver transplanted child.
CASE REPORT
An 18-month-old female child received a liver transplant in October 2015 for progressive familial intrahepatic cholestasis and was discharged after an uneventful postoperative period in stable condition. No intra-abdominal mass lesions were detected on radiology before and soon after the transplant. In May 2016, she presented with fever and distended abdomen. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Case Report mesenchymal neoplasm, positive for vimentin and SMA [ Figure 1 ]. All other markers, such as caldesmon, C-kit, CD 34, S100, and CD 31, were negative. Because the MIB-1 index was 15-20%, the suspicion of malignancy was high. A more representative sample was required for final tumor typing. The patient was operated upon, with a plan to resect all the tumors.
Two large masses measuring 16 cm and 8 cm in their maximum dimensions and two smaller nodules (0.5 cm, 1 cm) attached to the bowel were excised. Their external surface was uniform smooth and gray white. The cut section was vaguely lobulated, gray white, and myxoid. Tumor masses from omentum and small bowel showed large areas of necrosis and hemorrhage. Histomorphology reveals plump epithelioid to spindle-shaped cells with indistinct pale, eosinophilic cytoplasm. Pleomorphic nuclei show vesicular chromatin and distinct nucleoli. A rich network of thin-walled delicate capillaries with lympho-plasmacytic infiltrate and few neutrophils. Mitotic figures are rare [ Figure 2 ].
The morphology and initial immuno-profile suggested differential diagnoses of myxofibroblastic sarcoma, low-grade fibromyxoid sarcoma, and IMT. In view of positivity for vimentin, desmin, SMA, ALK-1, and Ki-67 index of 15-20%
[ Figure 3 ], a diagnosis of EBV-negative IMT, possibly of epithelioid type was established.
DISCUSSION
De novo neoplasms account for almost 30% of deaths 10 years after liver transplantation and are the most common causes of mortality in patients surviving at least 1 year after transplant. The risk of malignancy is 2-4 times higher in transplant recipients than in an age-and sex-matched population. [7] Skin cancers, lymphomas, and Kaposi sarcomas occur most frequently which can be contributed to chronic immunosuppression after solid organ transplantation and EBV infection. [6, 7] IMT with prominent epithelioid cytomorphology is very rare. In 4 out of 73 cases studied, Cook et al. found round cell transformation and large polygonal cells with a large nuclei and prominent nucleoli in a loose, pale staining background. [8] One of these, 4 cases showed distinctive nuclear membrane staining pattern of ALK. In 2010, Butrynski et al. reported sustained partial response to the ALK inhibitor, Crizotinib, in a patient with ALK-translocated IMT with epithelioid cytomorphology. [9] The clinical, morphological, and immunohistochemical features of 20 cases of reported EIMS are summarized in Table 1 . All of these showed increased expression of ALK protein resulting from 
